Test member news with topics tagging

Stablepharma and AJ Vaccines have established the primary commercial distribution deal with proposed terms, in relation to the distribution and commercialisation of the SPVX02 (Td) in Europe, a fridge-free adult booster vaccine for the prevention of Tetanus & Diphtheria.

Cancer Research Horizons, the innovation arm of Cancer Research UK, is partnering with Diamond Light Source, the UK’s national synchrotron, to build a world-leading fragment-based drug discovery programme.

As we engage as an Association in the development of the life science sector plan, the 10 year NHS plan and the UK’s industrial strategy this winter, this week I’ve been reflecting on what recent NHS announcements on adoption of innovation tell us.

When comparing the UK’s RNA manufacturing capability now, to that of before COVID-19, it is obvious that great advancements have been made. Abby Clark, Senior Manufacturing Programme Executive at the BIA, reflects on the past (nearly) five years and highlights recent work in the area.  

UCL’s Policy Impact Unit, who work closely with researchers in VaxHub Sustainable, VaxHub Global and the FTHM Hub, have recently published a position paper.